LCN2 and oculocutaneous albinism type 1: We validated several of their findings,including (i) a NGAL's accuracy in differentiating ATN from other AKIs (Cstatistic 0.87 in Barcelona compared with 0.77 in our cohort), (ii) a similaroptimal cutpoint (220 versus 243 μg/g), and (iii) that NGAL served as a strongshort-term predictor of mortality.